SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2012 / Cilt: 40 - Sayı: 4

Amerika Birleşik Devletleri ve Türkiye de koroner arter hastalığı nedeni ile güçlendirilmiş eksternal kontrpulsasyon tedavisi gören hastalarda olaysız sağkalım oranları ve uzun dönem klinik sonuçlarının karşılaştırılması

Comparison of long term clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation for coronary artery disease in the United States and Turkey

Bilal ÇUĞLAN
Coşkun İKİZLER
Özlem SORAN
Atilla ŞENGÜL
Elizabeth KENNARD
Sheryl KELSEY
Pages
323–330
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: TR patients had less diabetes, hypertension, and hyperlipidemia than US patients (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study assessed the long-term efficacy of EECP (Enhanced External Counterpulsation) in Turkish (TR) patients initially and compared these results with the United States (US) in a real world setting.
📊
Key Findings & Data:Study design: In this study, 2072 patients were treated and followed in the US and 82 patients were treated and followed in TR.
💡
Conclusion & Impact:Results: TR patients had less diabetes, hypertension, and hyperlipidemia than US patients (p
🔬Design:Research Article
📍Scope:2072 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study assessed the long-term efficacy of EECP (Enhanced External Counterpulsation) in Turkish (TR) patients initially and compared these results with the United States (US) in a real world setting. Study design: In this study, 2072 patients were treated and followed in the US and 82 patients were treated and followed in TR. The International EECP Patient Registry Phase I and II was initiated and coordinated at the University of Pittsburgh. The aim of the registry was to assess the outcomes of clinical trials in a real world setting. Another unique feature of this study was to enroll patients not only from university hospitals but also from private hospitals, educational hospitals, and treatment centers. Results: TR patients had less diabetes, hypertension, and hyperlipidemia than US patients (p

Özet

Amaç: Güçlendirilmiş eksternal kontrpulsasyon (EECP) tedavisi gören ilk Türk (TR) hasta grubunun klinik sonuçları, Amerika Birleşik Devletlerindeki (ABD) sonuçlarla karşılaştırıldı ve EECPnin uzun dönem etkinliği değerlendirildi. Çalışma planı: Bu çalışmada, ABDden 2072 hasta, TRden 82 hasta tedavi edilerek izlendi. The International EECP Patient Registry Phase I and II Pittsburgh Üniversitesinde başlatılıp ve koordine edildi. Kayıtların amacı, klinik çalışma sonuçlarını gerçek yaşam şartlarında değerlendirmekti. Bu çalışmanın bir diğer önemli özelliği ise sadece üniversite hastaneleri değil, aynı zamanda özel hastaneler, eğitim hastaneleri ve tedavi merkezlerinden de hasta alınmasıydı. Bulgular: TR hastalarda diyabet, hipertansiyon, hiperlipidemi daha azdı (p

🔖

Cite This Article

ÇUĞLAN, B., İKİZLER, C., SORAN, Ö., ŞENGÜL, A., KENNARD, E., KELSEY, S. (2022). Amerika Birleşik Devletleri ve Türkiye de koroner arter hastalığı nedeni ile güçlendirilmiş eksternal kontrpulsasyon tedavisi gören hastalarda olaysız sağkalım oranları ve uzun dönem klinik sonuçlarının karşılaştırılması. Türk Kardiyoloji Derneği Arşivi, Cilt: 40 - Sayı: 4, 323–330. https://ajindex.com/articles/633069

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Soran O, Kennard ED, Kfoury AG, Kelsey SF; IEPR Investigators. Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). Am J Cardiol 2006;97:17-20
  2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010;121:e46-e215
  3. Onat A, Keleş İ, Çetinkaya A, Başar Ö, Yıldırım B, Erer B, et al. Prevalence of coronary mortality and morbidity in the Turkish Adult Risk Factor Study: 10-year followup suggests coronary “Epidemic”. Arch Turk Soc Cardiol 2001;29:8-19
  4. Unuvar N. Türkiye hastalık yükü çalışması. http://tusak. saglık.gov.tr, 2004
  5. Onat A, Murat SN, Çiçek G, Ayhan E, Örnek E, Kaya H, et al. Regional distribution of all-cause mortality and coronary disease incidence in Turkey: findings of Turkish Adult Risk Factor survey 2010. Arch Turk Soc Cardiol 2011;39:263-8
  6. Manchanda A, Soran O. Enhanced external counterpulsa- tion and future directions: step beyond medical management for patients with angina and heart failure. J Am Coll Cardiol 2007;50:1523-31
  7. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exerciseinduced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999;33:1833-40
  8. Braith RW, Conti CR, Nichols WW, Choi CY, Khuddus MA, Beck DT, et al. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation 2010;122:1612-20
  9. Wu G, Du Z, Hu C, Zheng Z, Zhan C, Ma H, et al. Angiogenic effects of long-term enhanced external counterpulsation in a dog model of myocardial infarction. Am J Physiol Heart Circ Physiol 2006;290:H248-54
  10. Zheng ZS, Li TM, Kambic H, Chen GH, Yu LQ, Cai SR, et al. Sequential external counterpulsation (SECP) in China. Trans Am Soc Artif Intern Organs 1983;29:599-603
  11. Lawson WE, Hui JC, Soroff HS, Zheng ZS, Kayden DS, Sasvary D, et al. Efficacy of enhanced external counterpulsationin the treatment of angina pectoris. Am J Cardiol 1992;70:859- 62
  12. Lawson WE, Hui JC, Zheng ZS, Burger L, Jiang L, Lillis O, et al. Can angiographic findings predict which coronary patients will benefit from enhanced ext